ID   UBP37_MOUSE             Reviewed;         979 AA.
AC   Q8C0R0; B2RT12; Q69ZF6; Q8BZE6;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 132.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 37;
DE            EC=3.4.19.12 {ECO:0000250|UniProtKB:Q86T82};
DE   AltName: Full=Deubiquitinating enzyme 37;
DE   AltName: Full=Ubiquitin thioesterase 37;
DE   AltName: Full=Ubiquitin-specific-processing protease 37;
GN   Name=Usp37 {ECO:0000312|MGI:MGI:2442483};
GN   Synonyms=Kiaa1594 {ECO:0000312|EMBL:BAD32488.1};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAC26734.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-779 (ISOFORM 2).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAC26734.1};
RC   TISSUE=Testis {ECO:0000312|EMBL:BAC26734.1}, and
RC   Urinary bladder {ECO:0000312|EMBL:BAC29135.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAD32488.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 51-979 (ISOFORM 2).
RC   TISSUE=Pancreatic islet {ECO:0000312|EMBL:BAD32488.1};
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-650 AND SER-652, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Deubiquitinase that antagonizes the anaphase-promoting
CC       complex (APC/C) during G1/S transition by mediating deubiquitination of
CC       cyclin-A (CCNA1 and CCNA2), thereby promoting S phase entry.
CC       Specifically mediates deubiquitination of 'Lys-11'-linked polyubiquitin
CC       chains, a specific ubiquitin-linkage type mediated by the APC/C
CC       complex. Also mediates deubiquitination of 'Lys-48'-linked
CC       polyubiquitin chains in vitro. Phosphorylation at Ser-628 during G1/S
CC       phase maximizes the deubiquitinase activity, leading to prevent
CC       degradation of cyclin-A (CCNA1 and CCNA2). Plays an important role in
CC       the regulation of DNA replication by stabilizing the licensing factor
CC       CDT1. {ECO:0000250|UniProtKB:Q86T82}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:Q86T82};
CC   -!- SUBUNIT: Interacts with FZR1/CDH1. Interacts with CDT1.
CC       {ECO:0000250|UniProtKB:Q86T82}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:16141072};
CC         IsoId=Q8C0R0-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15368895, ECO:0000269|PubMed:16141072};
CC         IsoId=Q8C0R0-2; Sequence=VSP_052196;
CC   -!- DOMAIN: The KEN box 3 is required for interaction with FZR1/CDH1 and is
CC       essential for APC(CDH1)-mediated ubiquitination.
CC       {ECO:0000250|UniProtKB:Q86T82}.
CC   -!- PTM: Polyubiquitinated via 'Lys-11'-linked ubiquitin by the APC(CDH1)
CC       complex during late mitosis, leading to its degradation. Able to
CC       mediate auto-deubiquitination. {ECO:0000250|UniProtKB:Q86T82}.
CC   -!- PTM: Phosphorylated at Ser-628 by CDK2 during G1/S phase but not during
CC       mitosis; phosphorylation at Ser-628 is required for deubiquitinase
CC       activity. Also polyubiquitinated during early G1 phase, without leading
CC       to degradation. {ECO:0000250|UniProtKB:Q86T82}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK030013; BAC26734.1; -; mRNA.
DR   EMBL; AK035640; BAC29135.1; -; mRNA.
DR   EMBL; AK173210; BAD32488.1; -; mRNA.
DR   EMBL; BC139091; AAI39092.1; -; mRNA.
DR   CCDS; CCDS15050.1; -. [Q8C0R0-1]
DR   CCDS; CCDS78616.1; -. [Q8C0R0-2]
DR   RefSeq; NP_001297591.1; NM_001310662.1. [Q8C0R0-2]
DR   RefSeq; NP_795946.2; NM_176972.4.
DR   RefSeq; XP_006496117.1; XM_006496054.3.
DR   SMR; Q8C0R0; -.
DR   BioGRID; 235424; 2.
DR   STRING; 10090.ENSMUSP00000140670; -.
DR   iPTMnet; Q8C0R0; -.
DR   PhosphoSitePlus; Q8C0R0; -.
DR   jPOST; Q8C0R0; -.
DR   PaxDb; Q8C0R0; -.
DR   PeptideAtlas; Q8C0R0; -.
DR   PRIDE; Q8C0R0; -.
DR   ProteomicsDB; 298361; -. [Q8C0R0-1]
DR   ProteomicsDB; 298362; -. [Q8C0R0-2]
DR   Antibodypedia; 34273; 152 antibodies.
DR   Ensembl; ENSMUST00000044260; ENSMUSP00000035445; ENSMUSG00000033364. [Q8C0R0-2]
DR   GeneID; 319651; -.
DR   KEGG; mmu:319651; -.
DR   UCSC; uc007bmc.2; mouse. [Q8C0R0-2]
DR   UCSC; uc007bmd.2; mouse. [Q8C0R0-1]
DR   CTD; 57695; -.
DR   MGI; MGI:2442483; Usp37.
DR   eggNOG; KOG1868; Eukaryota.
DR   GeneTree; ENSGT00940000158091; -.
DR   HOGENOM; CLU_012557_0_0_1; -.
DR   InParanoid; Q8C0R0; -.
DR   OrthoDB; 129045at2759; -.
DR   PhylomeDB; Q8C0R0; -.
DR   TreeFam; TF323032; -.
DR   Reactome; R-MMU-5689880; Ub-specific processing proteases.
DR   BioGRID-ORCS; 319651; 13 hits in 52 CRISPR screens.
DR   ChiTaRS; Usp37; mouse.
DR   PRO; PR:Q8C0R0; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q8C0R0; protein.
DR   Bgee; ENSMUSG00000033364; Expressed in spermatocyte and 249 other tissues.
DR   Genevisible; Q8C0R0; MM.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; ISS:UniProtKB.
DR   GO; GO:0035871; P:protein K11-linked deubiquitination; ISS:UniProtKB.
DR   GO; GO:0071108; P:protein K48-linked deubiquitination; ISS:UniProtKB.
DR   GO; GO:0006275; P:regulation of DNA replication; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   CDD; cd13312; PH_USP37_like; 1.
DR   Gene3D; 2.30.29.180; -; 1.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR003903; UIM_dom.
DR   InterPro; IPR032069; USP37-like_PH.
DR   InterPro; IPR038093; USP37-like_PH_sf.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF16674; UCH_N; 1.
DR   Pfam; PF02809; UIM; 3.
DR   SMART; SM00726; UIM; 3.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS50330; UIM; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Hydrolase; Mitosis;
KW   Phosphoprotein; Protease; Reference proteome; Repeat; Thiol protease;
KW   Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN           1..979
FT                   /note="Ubiquitin carboxyl-terminal hydrolase 37"
FT                   /id="PRO_0000259610"
FT   DOMAIN          341..951
FT                   /note="USP"
FT   DOMAIN          704..723
FT                   /note="UIM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   DOMAIN          806..825
FT                   /note="UIM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   DOMAIN          828..847
FT                   /note="UIM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   MOTIF           32..34
FT                   /note="KEN box 1"
FT                   /evidence="ECO:0000250"
FT   MOTIF           71..79
FT                   /note="D-box 1"
FT                   /evidence="ECO:0000250"
FT   MOTIF           96..105
FT                   /note="D-box 2"
FT                   /evidence="ECO:0000250"
FT   MOTIF           160..168
FT                   /note="D-box 3"
FT                   /evidence="ECO:0000250"
FT   MOTIF           222..224
FT                   /note="KEN box 2"
FT                   /evidence="ECO:0000250"
FT   MOTIF           782..784
FT                   /note="KEN box 3"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        350
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q86T82,
FT                   ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-
FT                   ProRule:PRU10093"
FT   ACT_SITE        906
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86T82"
FT   MOD_RES         628
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q86T82"
FT   MOD_RES         650
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         652
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         770
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86T82"
FT   VAR_SEQ         612..634
FT                   /note="ISRPLRACQMMNSCITSPSAPSK -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15368895,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_052196"
FT   CONFLICT        622
FT                   /note="M -> V (in Ref. 2; AAI39092)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   979 AA;  110063 MW;  FF11DB673C1CA902 CRC64;
     MSPLKIYGPI RIRSMQTGIT KWKEGSFEIV EKDNRVSLLV HYNTGGIPRV FQLSHNIKNV
     VLRPSGIKQS RLMLTLQDNS FLSIDKVPSK DAEEMRLFLD AVHQNRLHAA MKASQGSGSF
     GTILGSRTSQ KETNRQLSYS DNQASSKRGS LETKDEIPFR KVLGSPGRGP IKTVTGGGMA
     VTRTIPSLTL TSTPLRSGLL ENRTEKRKRM LSGSELTEDY PKENDSSSNN KAMTDPSRKY
     LTSCREKQLS LKQAEENRTS GLLPLQSSSF YGSRAGSKDY SSGVTNLDRC NVSSQTPSAK
     RSLGFLPQPT PLSVKKLRCN QDYAGWNRPR VPLSSHQQQL QGFSNLGNTC YMNAILQSLF
     SLQSFANDLL KQSIPWKKIP FNALIRRFAN LLIKKDICNS ETKKELLKKV KNAISATAER
     FSGYVQNDAH EFLSQCLDQL KEDMEKLNKT WKTEPVLGEE NLPDTSATKV FTCPVITNLE
     FEVQHSIICK ACGETIPKRE QFNDLSIDLP RRKKPLPPRS IQDSLDLFFR AEELEYSCEK
     CGGKCALVRH KFNRLPRVLI LHLKRYSFNV ALSLNNKLGQ QVIIPRFLTL ASHCTESTKP
     PVTLGWSAPV AISRPLRACQ MMNSCITSPS APSKKFTFKS KSSVTSCLDS DSEDELKRSV
     VLSQRLCDLP GNEQYQEDVE KDLKLCRLEP GKAELENSGF DRMSEEEVLA AVLEISRREA
     SPVLSPEDDD KPTSSPDTGF AEDDIPEMPE NPDAMEIEKS KTITEPGPAS FTEITKDCDE
     NKENKTPEGS QGEVDWLQQY DVDREREEQE LQQALAQSLQ EQEAWEQKED DDLKRATELS
     LQEFNNSFLD SLGSDEDSGN EDVFDMEYTE AEAEELKRNA ETGALPHSYR LISVVSHIGS
     TSSSGHYISD VYDIKKQAWF TYNDLEVSKI QEAAVQSDRD RSGYIFFYMH KEIFDELLET
     EKTSQALSME VGRAARQAS
//
